Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
126 Rossi, Levati, and Biondi<br />
16. Müller, M. C., Merx, K., Weisser, A., Lahaye, T., Hehlmann, R., and Hochhaus,<br />
A. (2002) Improvement of molecular monitoring of residual disease in leukemias<br />
by bedside RNA stabilization. <strong>Leukemia</strong> 16, 2395–2399.<br />
17. van der Velde, V. H. J., Boeckx, N., Gonzalez, M., et al. (2004) Differential stability<br />
of control gene and fusion gene transcripts over time may hamper accurate<br />
quantification of minimal residual disease- a study within the Europe Against<br />
Cancer Program. <strong>Leukemia</strong> 18, 884–886.<br />
18. Gabert, J., Beillard, E., van der Velden, V. H. J., et al. (2003) Standardization and<br />
quality control studies of “real-time” quantitative reverse transcriptase polymerase<br />
chain reaction of fusion gene transcripts for residual disease detection in leukemia—A<br />
Europe Against Cancer Program. <strong>Leukemia</strong> 17, 2318–2357.<br />
19. Beillard, E., Pallisgaard, N., van der Velde, V. H. J., et al. (2003) Evaluation of<br />
candidate control genes for diagnosis and residual disease detection in leukemic<br />
patients using “real-time” quantitative reverse-transcriptase polymerase chain<br />
reaction (RQ-PCR)—a Europe against cancer program. <strong>Leukemia</strong> 17, 2474–2486.
Change language